PATENT CLAIM ANALYSIS

Application Number: 16083624
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "291000"]

Abstract:
The present invention concerns the use of an H4 agonist molecule against histamin, enantiomers of (AMINO-7 TRIETHOXY-4,5,6 OXO-1 DIHYDRO-1,3 ISOBENZOFURANNYL-3)-1 METHOXY-8 METHYL-METHYLENEDIOXY-6,7 TETRAHYDRO-,2,3,4 ISOQUINOLINE or tritoqualine, for the treatment of idiopathic pulmonary fibrosis.

Claim (Index 7):
Substance for its use according to  claim 5 , wherein it is packaged under different dosage forms: soft capsules, tablets, capsules, syrup, gel.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 97.0
- Lexical Diversity: 1.11429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13648543', '12124494', '15122241', '14883370', '15495806']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7456313074618408
- 35 USC 102 Novelty (BERT): 0.5056949866134913
- Combined Prediction Score: 0.721637675377006
- Mean Citation Score: 179.80354000000003
- Max Citation Score: 183.51843
- Similarity Product: 105.00111835523845

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test